Developing new methods to create complex molecules for potential drug development
Supplement: Studies in the Synthesis of Complex Organic Molecules with Donor-Donor Carbenes
This study is looking at new ways to quickly make complex molecules that could help create new medicines for treating various diseases, making it easier to find drug options that aren't currently available.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11029481 on NIH RePORTER |
What this research studies
This research focuses on creating innovative synthetic methods to rapidly prepare complex organic molecules that could lead to new drug discoveries. By exploring the reactivity of rhodium donor-donor carbenes, the project aims to unlock new chemical reactions that can produce useful compounds. The researchers will investigate how these carbenes can be utilized in various applications, particularly in creating small molecules that are essential for treating both acute and chronic diseases. The ultimate goal is to enhance the accessibility of novel drug candidates that are not currently available due to patent restrictions.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals suffering from acute and chronic diseases that currently lack effective treatment options.
Not a fit: Patients with conditions that are already well-managed by existing therapies may not see significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs that improve treatment options for various diseases.
How similar studies have performed: Previous research has shown promise in developing new synthetic methods for drug discovery, indicating that this approach could yield significant advancements.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Shaw, Jared Thomas — University of California at Davis
- Study coordinator: Shaw, Jared Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.